Thursday, February 25, 2016 6:06:32 PM
Posted by Logan Wallace on Feb 25th, 2016--- Rhenman & Partners Asset Management maintained its stake in Anthera Pharmaceuticals Inc (NASDAQ:ANTH) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 250,000 shares of the biopharmaceutical company’s stock at the end of the fourth quarter. Rhenman & Partners Asset Management owned about 0.63% of Anthera Pharmaceuticals worth $1,160,000 at the end of the most recent quarter.
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) traded down 2.34% during mid-day trading on Thursday, hitting $2.92. The company had a trading volume of 335,731 shares. The firm’s market capitalization is $116.44 million. Anthera Pharmaceuticals Inc has a 12 month low of $2.28 and a 12 month high of $11.65. The company has a 50-day moving average price of $3.12 and a 200 day moving average price of $5.59.
ANTH has been the subject of a number of analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $4.25 price target for the company in a research report on Monday, January 11th. Jefferies Group restated a “buy” rating and issued a $9.00 price target (down previously from $12.00) on shares of Anthera Pharmaceuticals in a research report on Friday, February 19th. Finally, Citigroup Inc. reduced their price target on Anthera Pharmaceuticals from $15.00 to $11.00 in a research report on Friday, February 19th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $10.45.--- http://www.tickerreport.com/banking-finance/1432922/rhenman-partners-asset-management-has-1160000-position-in-anthera-pharmaceuticals-inc-anth/
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM